About

We’re bringing together a curated group of founders, technical leaders, and investors at BIO International for an afternoon focused on the next wave of innovation in digital biology.

Hosted by NVIDIA, Nebius, and J.P. Morgan, this session will explore how startups are leveraging accelerated computing and AI to transform bioinformatics, genomics, and drug discovery.

This is a founder-first, technical session designed for CEOs, CTOs, and builders working at the intersection of AI and life sciences.

Please join the waitlist, and our team will reach out.

Register

Agenda

12:00 p.m. – 1:00 p.m.
Welcome and Introductions
1:00 p.m. – 2:00 p.m.
Roundtable Discussion led by NVIDIA & Nebius experts
2:00 p.m. – 2:30 p.m.
State of the HCLS AI market, led by JPMorgan
2:30 p.m. – 3:30 p.m.
VC panel + Q&A
3:30 p.m. – 4:00 p.m.
Final remarks and close

Location Details

The session will be a 7-minute walk from the conference.

The exact address will be shared via your confirmation email.

Join the Waitlist

More Resources

Nebius AI Cloud for Life Sciences and Healthcare

Nebius delivers scalable HPC and AI cloud infrastructure for genomics, drug discovery, and biotech, purpose-built for life sciences.

Learn more >

Nebius Customer Stories

See how leading AI and life sciences companies build, train, and deploy models on Nebius AI Cloud.

Learn more >

Latent Labs Speeds Up Generative AI for Drug Discovery

Latent Labs achieved 4x training speedups and 60% faster inference on NVIDIA Blackwell GPUs, accelerating drug discovery pipelines.

Learn more >